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ABSTRACT 
The rationale of this investigation is to design an immediate release oral dosage of Sumatriptan succinate by using microcrystalline 
cellulose as filler, camphor and menthol as subliming agents by direct compression method .The basic objective of this dissertation 
is to develop an orodispersible tablet of sumatriptan succinate used in anti-migraine with an aim of reduces the lag time and 
providing faster onset of action to relief the acute migraine effect immediately. Disintegrates and disperses in oral cavity within 30 
seconds without the need of drinking water. Has pleasant mouth feel and there is no after taste or grittiness. Successfully 
discriminates the ability of three superdisintegrants to promote drug dissolution and proposes a model formulation for disintegrants 
performance testing and quality control purposes. The formulation F6 containing 8% of CCS and 10% of menthol showed 
disintegration time of 18seconds after drying. Menthol as subliming agent was found to be most effective of all other subliming 
agents as it had showed drastic effect on the drug release. 
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INTRODUCTION 
 Immediate release drug delivery system 
Immediate release drug delivery system is also 
conventional type of drug delivery system as it is 
defined as immediate release tablets are designed to 
disintegrate and release their medicaments with no 
special rate controlling features such as special coatings 
and other techniques
1, 2
 
Advantages of immediate release drug delivery 
systems: 
 Release the drug immediately. 
 More flexibility2 for adjusting the dose. 
 It can be prepared with minimum dose of drug. 
 There is no dose dumping problem. 
 Immediate release drug delivery systems used in 
both initial stage and final stage of disease. 
 At the particular site of action the drug is released 
from the system. 
 
Sublimation
3
 is the process of transformation directly 
from the solid phase to the gaseous phase without 
passing through an intermediate liquid phase. 
Sublimation is an endothermic phase transition that 
occurs at temperatures and pressures below a 
substance's triple point in its phase diagram. 
At normal pressures, most chemical 
compounds and elements possess three different states at 
different temperatures. In these cases, the transition from 
the solid to the gaseous state requires an intermediate 
liquid state. Note, however, that the pressure referred to 
here is the partial pressure of the substance, not 
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the total (e.g., atmospheric) pressure of the entire 
system. So, all solids that possess an appreciable vapor 
pressure at a certain temperature usually can sublime in 
air (e.g., water ice just below 0°C). For some substances, 
such as carbon and arsenical, sublimation is much easier 
than evaporation from the melt, because the pressure of 
their triple point is very high, and it is difficult to obtain 
them as liquids. 
Sublimation requires additional energy and is 
an endothermic change. The enthalpy of 
sublimation (also called heat of sublimation) can be 
calculated as the enthalpy of fusion plus the enthalpy of 
vaporization. The reverse process of sublimation 
is deposition. The formation of frost is an example of 
meteorological deposition
4
. 
The key to rapid disintegration for mouth dissolving 
tablets
5, 6 
is the presence of a porous structure in the 
tablet matrix. Conventional compressed tablets that 
contain highly water-soluble ingredients often fall to 
dissolve rapidly because of low porosity of the matrix. 
Hence to generate porous matrix, volatile ingredients are 
used that are later subjected to a process of sublimation. 
In studies conducted by Heinemann and Rothe, Knitsch 
et al., and Roser and Blair, inert solid ingredients that 
displayed high volatility (e.g., ammonium bicarbonate, 
ammonium carbonate, benzoic acid, camphor, 
hexamethonium tetramine, naphthalene, phthalic 
anhydride, urea, and urethane were compressed along 
with other excipients into a tablet. The volatile material 
was then removed by sublimation, leaving behind a 
porous matrix. Solvents such as cyclohexane and 
benzene were also suggested for the generation of 
porosity in the matrix. 
MATERIALS AND METHODS 
Sumatriptan Succinate was obtained as gift sample from 
Chandra labs, Hyd, menthol, camphor, croscarmelose 
sodium, crospovidone, SSG, microcrystalline cellulose 
and magnesium stearate are of laboratory grade and 
purchased from ESSEL fine chem. Mumbai. 
Formulation
 7, 8, 9
 
Porous tablets of Sumatriptan succinate were prepared 
by direct compression method employing camphor and 
menthol as sublimating agents. The concentrations of the 
above ingredients were optimized as shown in below 
table on the basis of trial preparation of the tablets. All 
the ingredients were weighed accurately. The drug was 
mixed with the release rate enhancing disintegrants and 
other excipients, except magnesium stearate, in 
ascending order of their weight. The powder mix was 
blended for 20 min to have uniform distribution of drug 
in the formulation. Then, magnesium stearate was added 
and mixed for not more than 1 min (to ensure good 
lubrication.) About 200 mg of the powder mix was 
weighed accurately and fed into the die of single punch 
machinery and compressed using 8 mm flat- surface 
punches. The hardness of the tablets was adjusted at 4-6 
kg/cm
2
 using a Monsanto hardness tester. 
 
Table 1: Formulation design of Sumatriptan succinate immediate release tablets 
 
 
Preformulation: 
Organoleptic characters, Solubility, melting point and all 
other preformulation parameters were evaluated and 
results were shown. 
Drug- Excipient Compatibility studies 
10-12
 
FT-1R Studies: The IR absorption spectra of the 
Sumatriptan succinate drug and with different 
superdisintegrants, natural gums and excipients were 
taken in the range of 4000-450 cm
-1
 using KBr disc 
method, 1-2 mg of the substance to be examined was 
triturated with 300-400 mg, specified quantity, of finely 
powered and dried potassium bromide. These quantities 
are usually sufficient to give a disc of 10-15mm 
diameter and pellet of suitable intensity by a hydraulic 
press. The scans were evaluated for presence of principle 
peaks of drug, shifting and masking of drug peaks due 
presence superdisintegrants, natural gums, polymers and 
excipients.
 
 
 
Ingredients  F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
Sumatriptan 
succinate 
25mg 
25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 25mg 
Menthol 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg 20mg - 
Camphor           20mg 
MCC 145 141 137 145 141 137 145 141 137 137 
SSG 8mg 12mg 16mg - - - - - - - 
CCS - - - 8mg 12mg 16mg - - - 16mg 
CP - - - - - - 8mg 12mg 16mg - 
Mg.stearate 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 2mg 
Total weight 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 200mg 
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Evaluation: 
Pre-compression parameters: 
 Angle of repose 4 
A funnel with 10 mm inner diameter of stem was fixed 
at a height of 2 cm. over the platform. About 10 gm of 
sample was slowly passed along the wall of the funnel 
till the tip of the pile formed and touches the steam of 
the funnel. A rough circle was drawn around the pile 
base and the radius of the powder cone was measured. 
 Bulk density and tapped density8 
Apparent Bulk density (gm/ml) of the drug was 
determined by pouring (pre-sieved 40-mesh) gently 25 
gm of sample through a glass funnel into a 100 ml 
graduated cylinder. Then after pouring the powder bed 
was made uniform without disturbing. Then the volume 
was measured directly from the graduation marks on the 
cylinder as ml. The volume measure was called as the 
bulk volume and the bulk density was calculated by 
following formula. 
Bulk density = weight of the sample/bulk volume 
Tapped densities the drug was determined by pouring 
gently 25 gm of sample through a glass funnel into a 100 
ml graduated cylinder. The cylinder was tapped from 
height of 2 inches until a constant volume was obtained. 
In USP TAP DENSITY TESTER, Tap density is 
measured in 500taps, 750 taps & 1250taps with 
drop/time-299-302. Volume occupied by the sample 
after tapping were recorded and tapped density was 
calculated.  
Tapped density = weight of the sample/ volume 
occupied by the sample after tapping 
 Compressibility (Carr’s compressibility index) 
Compressibility is the ability of powder to decrease in 
volume under pressure. Compressibility is a measure 
that is obtained from density determinations. It is also 
one of the simple methods to evaluate flow property of 
powder by comparing the bulk density and tapped 
density. High density powders tend to possess free 
flowing properties. A useful empirical guide is given by 
the Carr’s index or compressibility index calculated 
from bulk density and tapped density. 
 Hausner’s ratio  
Hausner’s ratio provides an indication of the degree of 
densification which could result from vibration of the 
feed hopper. A lower value of indicates better flow and 
vice versa. 
Post compression parameters 
 Organoleptic properties of tablets 
Organoleptic properties such as taste, color, odour, were 
evaluated. Ten tablets from each batch were randomly 
selected and tested for taste, color, odour and physical 
appearance. 
 Thickness13 
The thickness of individual tablets of 6 numbers were 
measured with vernier calipers, it permits accurate 
measurements and provides information of the variation 
between tablets. Tablet thickness should be controlled 
within ± 5% variation of standard value.  
 Hardness  
The tablet hardness of different formulations was 
measured using the Monsanto hardness tester for 6 
tablets. The tester consists of a barrel containing a 
compressible spring held between two plungers. The 
lower plunger was placed in contact with the tablet, and 
a zero was taken. The upper plunger was then forced 
against the spring by turning a threaded bolt until the 
tablet fractures. As the spring is compressed, a pointer 
rides along a gauge on the barrel to indicate the force. 
The force of fracture is recorded and the zero force 
reading is deducted from it.  
 Weight Variation Test 
Twenty tablets from each batch were weighed with 
electronic digital balance and average weight was 
determined. Then individual tablets were weighted and 
individual weight was compared with the average 
weight. The percentage deviation was calculated and 
checked for weight variation. Standard deviation was 
calculated. Using this procedure weight variation range 
of all the batches were determined and recorded.  
 In vitro Disintegration time 8, 9 
The process of breakdown of a tablet into smaller 
particles is called as disintegration. The in-vitro 
disintegration time of a tablet was determined using 
disintegration apparatus as per I.P. specifications.  
I.P. Specifications: Place one tablet in each of the 6 
tubes of the basket. Add a disc to each tube and run the 
apparatus using 0.1N HCl maintained at 37±2C as the 
immersion liquid. The assembly should be raised and 
lowered between 30 cycles per minute in the 0.1N HCl 
maintained at 37±2c. The time in seconds taken for 
complete disintegration of the tablet with no palpable 
mass remaining in the apparatus was measured and 
recorded.  
 Drug Content Uniformity Assay 
Ten tablets were selected randomly and powdered. A 
quantity of this powder corresponding to one tablet was 
dissolved in 100 ml of 0.1N HCl , stirred for 15 min and 
filtered. 1 ml of the filtrate was diluted to 100 ml with 
0.1N HCl. Absorbance of this solution was measured at 
222nm using 0.1N HCl  as blank and content of drug 
was estimated.  
 In vitro Dissolution studies 10, 11, 13 
Dissolution of the tablet of each batch was carried out 
using USP type II apparatus (ELECTRO LAB) using 
paddles at 50 rpm. As per the official recommendation 
of IP 900ml of 0.1 N HCl used as dissolution medium 
and the temperature of the medium was set at 37 ± 0.5 
0
C. 5 ml of sample was withdrawn at predetermined time 
interval of 5min., 10min., 15min, 20min, 25min, 30min, 
35min and 40min. And same volume of fresh medium 
was replaced. The withdrawn samples were analyzed by 
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an UV-visible spectrophotometer at 222 nm using buffer 
solution as blank solution. 
The drug content was calculated using the equation 
generated from standard calibration curve. The % 
cumulative drug release was calculated. 
RESULTS AND DISCUSSION 
Preformulation Studies 
 Description: 
These tests were performed as per the procedure and the 
results were illustrated in the following table: 
Table 2: Table showing the description of 
Sumatriptan succinate (API) 
Test Description 
Color A white to off white colour crystalline powder 
Odor Odorless 
 
Organoleptic properties such as taste, color, odor were 
evaluated and the results are within the standards, shown 
in (Table.9). The drug is showing solubility in methanol 
and in water.  
 Solubility: 
These tests were performed as per procedure and the 
results are illustrated in the following table. The drug is 
showing solubility in methanol and in water.  
Table 3: showing the Solubility of Sumatriptan 
Succinate (API) in various solvents. 
Solvents Solubility 
0.1N HCL Freely soluble 
Water Freely soluble 
pH6.8Phosphate buffer Soluble 
Methanol Freely soluble 
Ethanol Slightly soluble 
 
 Melting Point: The melting point of sumatriptan 
succinate was found to be 170
0
c. 
 
 
Evaluation of tablet blend 
                     Table 4: Evaluation of tablet blend for formulations (F1 – F10) 
Formulation Bulk Density 
(g/cc) 
Tapped 
Density(g/cc) 
Hausner’s 
ratio 
Compressibility 
index (%) 
Angle of 
repose 
Flow 
properties 
F1 0.464 0.574 1.23 19.1 29.47 Excellent 
F2 0.423 0.501 1.16 15.5 27.63 Excellent 
F3 0.456 0.542 1.22 15.8 25.54 Excellent 
F4 0.467 0.559 1.25 16.4 26.23 Excellent 
F5 0.485 0.593 1.10 18.2 27.21 Excellent 
F6 0.460 0.556 1.21 17.2 30.38 Good 
F7 0.478 0.575 1.24 16.8 28.46 Excellent 
F8 0.450 0.554 1.28 18.7 25.71 Excellent 
F9 0.442 0.537 1.27 17.6 31.82 Good 
F10 0.467 0.559 1.25 16.4 26.23 Excellent 
 
All the formulations prepared by direct compression 
method showed the angle of repose less than 34, which 
reveals good flow property. The bulk density and tapped 
density for all formulation (F1 – F10) varied from 0.442 
- 0.485 gm/cm
3
 and 0.501 - 0.593 gm/cm
3
 respectively. 
The results of Carr’s consolidate index or % 
compressibility index and hausner’s ratio for the entire 
formulation (F1 – F10) blend range from 15.5- 19.1 and 
1.10-1.28 respectively, shows fair flow properties. The 
results are shown in the (Table.5).  
 
Drug-excipient compatibility studies 
The FT-IR represents the peaks of the Sumatriptan 
succinate functional groups. These peaks were not 
affected, they were prominently observed in IR-spectra 
of Sumatriptan succinate along with superdisintegrants 
and other excipients. The spectral details of the drug and 
the excipients are shown in (Figure.8 – 17). There was 
no difference in the position of the absorption bands, 
hence providing evidence for the absence of any 
chemical incompatibility between pure drugs with the 
excipients.
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                                               Figure 1: FTIR spectra of pure drug Sumatriptan 
 
                                           Figure 2: FTIR spectra of Optimized Formulation (F6)  
Post compression parameters 
Appearance of tablets 
All the tablets show similar color, odor, taste and physical appearance. There is no impact of superdisintegrants in their 
organoleptic properties. The results are shown in the (Table 6). 
Table 5: Organoleptic properties of tablets 
Color white 
Shape Round 
Texture Fine 
 
Evaluation of Tablets 
 Before Drying 
Table 6: Evaluation of Immediate Release Tablets For Formulations (F1 – F10) Before Drying 
Formulation Hardness
a
 
(kg/cm2) 
Weight
b
 (mg) Thickness
a
 
(mm) 
Disintegration 
time
a
 (min) 
Drug content
c 
(%) 
F1 6.0±0.17 201±0.59 2.4±0.05 6 98.2±0.62 
F2 6.1±0.20 198±0.63 2.4±0.02 5min 24sec 98.72±0.23 
F3 6.2±0.18 201±0.45 2.6±0.07 4min 98.4±0.34 
F4 6.0±0.15 202±0.88 2.5±0.10 5min 45sec 98±0.56 
F5 6.2±0.16 203±0.56 2.4±0.03 4min 34sec 98.44±0.49 
F6 6.1±0.22 198±0.74 2.45±0.06 2min 21sec 100.8±0.27 
F7 6.2±0.24 201±0.67 2.5±0.15 5min 32sec 98.2±0.63 
F8 6.0±0.22 201±0.77 2.5±0.03 4min 98.4±0.56 
F9 6.1±0.16 203±0.86 2.4±0.01 2 min17sec 99.32±0.37 
F10 6.1±0.12 198±0.54 2.4±0.05 2min 28sec 98±0.56 
a = 6 tablets, b = 20, c=10 
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 After Drying 
Table 7: Evaluation of Immediate Release Tablets For Formulations (F1 – F10) After Drying 
Formulation Hardness
a
 
(kg/cm2) 
Weight
b 
(mg) Thickness
a
 
(mm) 
Disintegration 
time
a
 (sec) 
Drug content
c 
(%) 
F1 3.5.0±0.11 181±0.39 2.4±0.03 1min 14sec 98.2±0.62 
F2 3.7±0.13 179±0.43 2.4±0.05 47sec 98.72±0.23 
F3 3.9±0.15 182±0.47 2.6±0.06 38sec 98.4±0.34 
F4 3.8±0.12 183±0.78 2.5±0.09 1min 98±0.56 
F5 3.7±0.12 184±0.43 2.4±0.05 42sec 98.44±0.49 
F6 3.6±0.19 183±0.51 2.45±0.08 18sec 100.8±0.27 
F7 3.6±0.21 181±0.55 2.5±0.12 45sec 98.2±0.63 
F8 3.9±0.25 183±0.57 2.5±0.06 28sec 98.4±0.56 
F9 3.8±0.19 184±0.56 2.4±0.07 19sec 99.32±0.37 
F10 3.7±0.16 183±0.31 2.4±0.08 22sec 98±0.56 
a = 6 tablets, b= 20, c=10 
By using the superdisintegrants, the hardness before 
drying values ranged from 6.0±0.15kg/cm
2
 - 
6.2±0.24kg/cm
2 
for formulations (F1- F10) and hardness 
after drying ranges from 3.5.0±0.11 kg/cm
2
 - 3.9±0.25 
kg/cm
2. 
The entire tablet passes weight variation test, as the 
average % weight variation was within the 
Pharmacopoeial limit - 7.5%. It was found to be 
198±0.54 mg - 203±0.56 mg( before drying),and after 
drying varies from 179±0.43mg-183±0.78mg. The 
weight of all the tablets was found to be uniform with 
less deviation.  
Disintegration test carried out in modified dissolution 
apparatus, Results shows the formulations with F1 (4%), 
F2(6%), F3(8%) of SSG having disintegrating 
time(After drying) as 1min 14sec, 47sec and 38sec 
respectively. F4 (4%), F5 (6%), F6(8%) of CCS having 
disintegrating time(After drying) as 1min, 42sec and 
18sec respectively. F7 (4%), F8(6%), F9(8%) of CP 
having high disintegrating time(After drying) as 45sec 
28sec and 19sec respectively.F10 (8%) of CCS  having 
disintegrating time of 22sec. The concentration of the 
drug in all the formulations with superdisintegrants was 
found to be 98±0.56– 100.8±0.27%. It was within the IP 
limits. The results of drug content of all batches are 
shown in (Table.8). 
  
Results of in-vitro release profile 
Table 8: In-Vitro Release Profile of Sumatriptan succinate from formulations F1-F10 
Time 
(min) 
Cumulative % drug release 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
5 13±0.0021 17±0.011 24±0.023 17±0.023 20±0.019 37±0.011 13±0.017 17±0.021 23±0.011 32±0.021 
10 23±0.019 27±0.014 38±0.025 32±0.019 38±0.014 55±0.017 27±0.021 31±0.025 37±0.009 53±0.019 
15 35±0.011 42±0.025 54±0.019 45±0.021 57±0.017 70±0.021 38±0.025 45±0.023 53±0.008 68±0.001 
20 56±0.016 59±0.021 67±0.023 56±0.025 65±0.018 86±0.022 51±0.019 57±0.026 68±0.012 82±0.007 
25 62±0.011 70±0.017 78±0.021 69±0.022 76±0.021 99±0.023 64±0.017 76±0.023 78±0.017 91±0.011 
30 77±0.021 83±0.022 91±0.017 86±0.021 93±0.023 102±0.027 79±0.016 84±0.021 97±0.019 99±0.021 
35 89±0.014 92±0.017 99±0.021 93±0.021 99±0.025  92±0.018 99±0.019 101±0.021 102±0.021 
40 101±0.013 98±0.021  101±0.018   99±0.021 102±0.017   
n=3 
Dissolution is carried out in USP apparatus type-2 
apparatus at 50rpm in 900ml dissolution media (0.1N 
HCl) for 40 minutes. At the end of 30 minutes almost 
total amount of the drug is released (i.e. 102±0.027 %), 
from the formulation prepared by the direct compression 
method with 8% crospovidone. 
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Figure 3: Linear graph comparison between 
cumulative % drug releases for formulations (F6 & 
F10) 
From the above Table 7, it is observed that the 
thickness, hardness, weight variation and drug content 
of the immediate release tablets were in the passable 
range. The F1,F2 and F3 formulations containing 
menthol as the subliming agent, SSG as super 
disintegrating agent in the percentage of 4%, 6% and 
8% didn’t show much effect on the Disintegration time 
i.e., 1min 14sec,47sec 38sec respectively and 
dissolution time i.e., 101% in 40min,98% in 40min and 
99% 35min respectively .  
The F4, F5 formulations containing menthol as the 
subliming agent, CCS as super disintegrating agent in 
the percentage of 4%, 6% didn’t show much effect on 
the Disintegration time i.e., 1min, 42sec respectively 
and dissolution time 101% in 40min and 99% in 35min 
respectively. Whereas F6 containing menthol as 
sublimating agent and 8% menthol as sublimating agent 
showed good disintegrating time i.e.,18sec and 
dissolution of 102% in 30min.   
The F7, F8 and F9 formulations containing menthol as 
the subliming agent, CP as super disintegrating agent in 
the percentage of 4%, 6% and 8% didn’t show much 
effect on the Disintegration time I.e., 45sec,28sec and 
19sec respectively, dissolution time of 99% in 
40min,102% in 40min and 101% in 35min respectively.  
The formulation F10 containing camphor as sublimating 
agent and 8% CCS as super disintegrating agent showed 
22sec disintegration time and 102% drug release in 
35min. 
Among the formulations F6 and F10  F6 was optimized 
as it showed less disintegration time and highest 
percentage of drug release (102%) in 30 min where as 
F10 showed disintegrating time of 22sec and 102% of 
drug release in 35min.  
CONCLUSION 
By studying all the experimental results it was 
conclusively demonstrated that the formulated 
immediate release tablets of sumatriptan succinate 
exhibited good physical parameters and rapidly 
disintegrating without affecting the release profile and is 
very effective. The overall results indicated that 
formulation with cross caramellose sodium (8%) as 
super disintegrants and menthol (10%) as sublimating 
agent had a higher edge compared to other formulations. 
They satisfy all the criteria for immediate release tablets 
and the direct compression process is simple, 
reproducible and robust to prepare immediate release 
tablets of other anti-migraine drugs. The formulation 
F6was the optimized formulation and  can be easily 
scaled up and can be easily employed in large scale 
production because the process is simple, cost effective 
and precise and also yields reproducible good results for 
manufacturing the tablets. 
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